# Real-world Evaluation of Tolerability, Safety and Efficacy of Rivastigmine Oral Solution in Patients with Mild to Moderate Alzheimer's Disease Dementia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-evaluation-of-tolerability-safety-and-efficacy-of-rivastigmine-oral/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sun‐Wung Hsieh,Jui‐Cheng Chen,Nai-Ching Chen,Kai-Ming Jhang,Wenfu Wang,Yuan‐Han Yang |
| Citations | 6 |
| DOI | 10.9758/cpn.2021.19.3.459 |
| Fields | Medicine,Neuroscience |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.cpn.or.kr/journal/download_pdf.php?doi=10.9758/cpn.2021.19.3.459 |
| OpenAlex ID | https://openalex.org/W3183430531 |
| PMID | 34294615 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Kai-Ming Jhang](https://scholariq.org/researchers/kai-ming-jhang/)

## Paper primary topic

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)

## Paper topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Neurological Disorders and Treatments](https://scholariq.org/topics/neurological-disorders-and-treatments-2/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.